Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Published in: European Journal of Nutrition 4/2016

01-06-2016 | Review

Coffee consumption, obesity and type 2 diabetes: a mini-review

Authors: Roseane Maria Maia Santos, Darcy Roberto Andrade Lima

Published in: European Journal of Nutrition | Issue 4/2016

Login to get access

Abstract

Purpose

The effects of regular coffee intake on weight gain and development of diabetes are reviewed. The pathophysiology of obesity and type 2 diabetes as well as the necessity of preventive options based on the increasing prevalence of these two disorders worldwide is briefly discussed. The relationship between weight gain and development of diabetes is also presented. The two major constituents in the brewed coffee, chlorogenic acids and caffeine, are responsible for many of the beneficial effects suggested by numerous epidemiological studies of coffee consumption and the development of diabetes.

Methods

A wide search of various databases, such as PubMed and Google Scholar, preceded the writing of this manuscript, focusing on key words that are part of the title. It was selected mainly review papers from in vivo, ex vivo, in vitro experimental studies in animals and human tissues as well as wide population-based epidemiological studies in the last 10 years.

Conclusion

As of today, there are mounting evidences of the reduced risk of developing type 2 diabetes by regular coffee drinkers of 3–4 cups a day. The effects are likely due to the presence of chlorogenic acids and caffeine, the two constituents of coffee in higher concentration after the roasting process.
Literature
1.
Leong KS, Wilding JP (1999) Obesity and diabetes. Bailliere’s Best Pract Res Clin Endocrinol Metab 13(2):221–237CrossRef
2.
3.
4.
5.
6.
Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G (1984) Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 288(6428):1401–1404CrossRef
7.
Astrup A, Finer N (2000) Redefining type 2 diabetes: ‘diabesity’ or ‘obesity dependent diabetes mellitus’? Obes 1(2):57–59
8.
9.
10.
International Diabetes F (2013) IDF Atlas 6th edition. Paper presented at the Sixty-Six World Health Assembly
11.
International Diabetes F (2013) IDF Atlas, 6th edn. IDF, Brussels, Belgium
12.
13.
Han TS, van Leer EM, Seidell JC, Lean ME (1995) Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311(7017):1401–1405CrossRef
14.
15.
Savva SC, Lamnisos D, Kafatos AG (2013) Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis. Diabetes Metab Syndr Obes Targets Ther 6:403–419. doi:10.​2147/​DMSO.​S34220 CrossRef
16.
17.
18.
Farah A, Duarte G (2015) Bioavailability and metabolism of chlorogenic acids from coffee. In: Preedy VR (ed) Coffee in health and disease prevention. Elsevier, New York
19.
Santos RML (2009) An unashamed defense of coffee: 101 reasons to drink coffee without guilt. XLibris, USA
20.
Esquivel P, Jimenez VM (2012) Functional properties of coffee and coffee by-products. Food Res Intern 46:488–495CrossRef
21.
Bekedam EK, Schols HA, Cammerer B, Kroh LW, van Boekel MA, Smit G (2008) Electron spin resonance (ESR) studies on the formation of roasting-induced antioxidative structures in coffee brews at different degrees of roast. J Agric Food Chem 56(12):4597–4604. doi:10.​1021/​jf8004004 CrossRef
22.
del Castillo MD, Ames JM, Gordon MH (2002) Effect of roasting on the antioxidant activity of coffee brews. J Agric Food Chem 50(13):3698–3703CrossRef
23.
24.
Astrup A, Toubro S, Cannon S, Hein P, Breum L, Madsen J (1990) Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr 51(5):759–767
25.
26.
Arciero PJ, Bougopoulos CL, Nindl BC, Benowitz NL (2000) Influence of age on the thermic response to caffeine in women. Metab Clin Exp 49(1):101–107CrossRef
27.
Astrup A, Toubro S (1993) Thermogenic, metabolic, and cardiovascular responses to ephedrine and caffeine in man. Int J Obes Relat Metab Disord J Int Assoc Study Obes 17(Suppl 1):S41–S43
28.
Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, Vandermander J (1999) Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70(6):1040–1045
29.
30.
Paluska SA (2003) Caffeine and exercise. Curr Sports Med Rep 2(4):213–219CrossRef
31.
Graham TE (2001) Caffeine, coffee and ephedrine: impact on exercise performance and metabolism. Can J Appl Physiol Revue canadienne de physiologie appliquee 26(Suppl):S103–S119
32.
33.
34.
Spriet LL (1995) Caffeine and performance. Int J Sport Nutr 5(Suppl):S84–S99
35.
Rustenbeck I, Lier-Glaubitz V, Willenborg M, Eggert F, Engelhardt U, Jorns A (2014) Effect of chronic coffee consumption on weight gain and glycaemia in a mouse model of obesity and type 2 diabetes. Nutr Diabetes 4:e123. doi:10.​1038/​nutd.​2014.​19 CrossRef
36.
Mellbye FB, Jeppesen PB, Hermansen K, Gregersen S (2015) Cafestol, a bioactive substance in coffee, stimulates insulin secretion and increases glucose uptake in muscle cells: studies in vitro. J Nat Prod 78(10):2447–2451. doi:10.​1021/​acs.​jnatprod.​5b00481 CrossRef
37.
38.
Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc 40(8):1155–1163CrossRef
39.
Cavin C, Mace K, Offord EA, Schilter B (2001) Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc 39(6):549–556CrossRef
40.
41.
Zanotti I, Dall’Asta M, Mena P, Mele L, Bruni R, Ray S, Del Rio D (2015) Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism. Food Funct 6(1):13–31. doi:10.​1039/​c4fo00670d CrossRef
42.
Tresserra-Rimbau A, Medina-Remon A, Estruch R, Lamuela-Raventos RM (2015) Coffee polyphenols and high cardiovascular risk parameters. In: Preedy VR (ed) Coffee in health and disease prevention. Elsevier Inc., New York, pp 387–394
43.
Olthof MR, Hollman PC, Katan MB (2001) Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131(1):66–71
44.
Olthof MR, Hollman PC, Buijsman MN, van Amelsvoort JM, Katan MB (2003) Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr 133(6):1806–1814
45.
Cowan TE, Palmnas MS, Yang J, Bomhof MR, Ardell KL, Reimer RA, Vogel HJ, Shearer J (2014) Chronic coffee consumption in the diet-induced obese rat: impact on gut microbiota and serum metabolomics. J Nutr Biochem 25(4):489–495. doi:10.​1016/​j.​jnutbio.​2013.​12.​009 CrossRef
46.
Lafay S, Gil-Izquierdo A, Manach C, Morand C, Besson C, Scalbert A (2006) Chlorogenic acid is absorbed in its intact form in the stomach of rats. J Nutr 136(5):1192–1197
47.
Redeuil K, Smarrito-Menozzi C, Guy P, Rezzi S, Dionisi F, Williamson G, Nagy K, Renouf M (2011) Identification of novel circulating coffee metabolites in human plasma by liquid chromatography-mass spectrometry. J Chromatogr A 1218(29):4678–4688. doi:10.​1016/​j.​chroma.​2011.​05.​050 CrossRef
48.
Fumeaux R, Menozzi-Smarrito C, Stalmach A, Munari C, Kraehenbuehl K, Steiling H, Crozier A, Williamson G, Barron D (2010) First synthesis, characterization, and evidence for the presence of hydroxycinnamic acid sulfate and glucuronide conjugates in human biological fluids as a result of coffee consumption. Org Biomol Chem 8(22):5199–5211. doi:10.​1039/​c0ob00137f CrossRef
49.
Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C (2002) Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem 50(21):6211–6216CrossRef
50.
51.
Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, Jacobs DR Jr, Ose L, Blomhoff R (2004) Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134(3):562–567
52.
Wang H-Y, Quian H, Yao W-R (2011) Melanoidins produced by the Maillard reaction: structure and biological activity. Food Chem 128:573–584CrossRef
53.
54.
Jimenez-Zamora A, Pastoriza S, Rufian-Henares J (2015) Revalorization of Coffee Byproducts. LWT Food Sci Technol 61:12–18CrossRef
55.
Cruz R, Mendes E, Torrinha A, Morais S, Pereira JA, Baptista P, Casal S (2014) Revalorization of spent coffee residues by direct agronomic approach. Food Res Int 73:190–196
56.
57.
Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101(44):15718–15723. doi:10.​1073/​pnas.​0407076101 CrossRef
58.
Mills CE, Tzounis X, Oruna-Concha MJ, Mottram DS, Gibson GR, Spencer JP (2015) In vitro colonic metabolism of coffee and chlorogenic acid results in selective changes in human faecal microbiota growth. Br J Nutr 113(8):1220–1227. doi:10.​1017/​S000711451400394​8 CrossRef
59.
Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A (2013) Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18(14):1818–1892. doi:10.​1089/​ars.​2012.​4581 CrossRef
60.
Narita Y, Inouye K (2009) Kinetic analysis and mechanism on the inhibition of chlorogenic acid and its components against porcine pancreas alpha-amylase isozymes I and II. J Agric Food Chem 57(19):9218–9225. doi:10.​1021/​jf9017383 CrossRef
61.
Vinson JA, Burnham BR, Nagendran MV (2012) Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects. Diabetes Metab Syndr Obes Targets Ther 5:21–27. doi:10.​2147/​DMSO.​S27665 CrossRef
62.
63.
Matsui T, Ueda T, Oki T, Sugita K, Terahara N, Matsumoto K (2001) alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity. J Agric Food Chem 49(4):1948–1951CrossRef
64.
Johnston KL, Clifford MN, Morgan LM (2003) Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 78(4):728–733
65.
Song SJ, Choi S, Park T (2014) Decaffeinated green coffee bean extract attenuates diet-induced obesity and insulin resistance in mice. Evid Based Complement Altern Med 2014:718379. doi:10.​1155/​2014/​718379
66.
Jia H, Aw W, Egashira K, Takahashi S, Aoyama S, Saito K, Kishimoto Y, Kato H (2014) Coffee intake mitigated inflammation and obesity-induced insulin resistance in skeletal muscle of high-fat diet-induced obese mice. Genes Nutr 9(3):389. doi:10.​1007/​s12263-014-0389-3 CrossRef
67.
68.
69.
Fukushima Y, Kasuga M, Nakao K, Shimomura I, Matsuzawa Y (2009) Effects of coffee on inflammatory cytokine gene expression in mice fed high-fat diets. J Agric Food Chem 57(23):11100–11105. doi:10.​1021/​jf901278u CrossRef
70.
Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, Shibuya Y, Hase T (2011) Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6 J mice. Am J Physiol Endocrinol Metab 300(1):E122–E133. doi:10.​1152/​ajpendo.​00441.​2010 CrossRef
71.
72.
Kim HJ, Takahashi M, Ezaki O (1999) Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. J Biol Chem 274(36):25892–25898CrossRef
73.
Malloy MJ, Kane JP (2015) Agents used in dyslipidemia. In: Katzung BG, Trevor AJ (eds) Basic and clinical pharmacology, 13th edn. McGraw Hill, United States
74.
Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS, Lee MK (2010) Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc 48(3):937–943. doi:10.​1016/​j.​fct.​2010.​01.​003 CrossRef
75.
76.
Yamauchi R, Kobayashi M, Matsuda Y, Ojika M, Shigeoka S, Yamamoto Y, Tou Y, Inoue T, Katagiri T, Murai A, Horio F (2010) Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice. J Agric Food Chem 58(9):5597–5603. doi:10.​1021/​jf904062c CrossRef
77.
Kodiha M, Stochaj U (2011) Targeting AMPK for therapeutic intervention in type 2 diabetes. Medical complications of type 2 diabetes, vol 1. InTech Europe, Croatia
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
Viollet B, Lantier L, Devin-Leclerc J, Hebrard S, Amouyal C, Mounier R, Foretz M, Andreelli F (2009) Targeting the AMPK pathway for the treatment of type 2 diabetes. Front Biosci (Landmark Ed) 14:3380–3400CrossRef
88.
Goto A, Chen BH, Song Y, Cauley J, Cummings SR, Farhat GN, Gunter M, Van Horn L, Howard BV, Jackson R, Lee J, Rexrode KM, Liu S (2014) Age, body mass, usage of exogenous estrogen, and lifestyle factors in relation to circulating sex hormone-binding globulin concentrations in postmenopausal women. Clin Chem 60(1):174–185. doi:10.​1373/​clinchem.​2013.​207217 CrossRef
89.
McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Wang CY (2006) Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) 14(9):1662–1677. doi:10.​1038/​oby.​2006.​191 CrossRef
90.
Anderson DC (1974) Sex-hormone-binding globulin. Clin Endocrinol 3(1):69–96CrossRef
91.
Goto A, Song Y, Chen BH, Manson JE, Buring JE, Liu S (2011) Coffee and caffeine consumption in relation to sex hormone-binding globulin and risk of type 2 diabetes in postmenopausal women. Diabetes 60(1):269–275. doi:10.​2337/​db10-1193 CrossRef
92.
Slow S, Miller WE, McGregor DO, Lee MB, Lever M, George PM, Chambers ST (2004) Trigonelline is not responsible for the acute increase in plasma homocysteine following ingestion of instant coffee. Eur J Clin Nutr 58(9):1253–1256. doi:10.​1038/​sj.​ejcn.​1601957 CrossRef
93.
Wu X, Skog K, Jagerstad M (1997) Trigonelline, a naturally occurring constituent of green coffee beans behind the mutagenic activity of roasted coffee? Mutat Res 391(3):171–177CrossRef
94.
95.
96.
van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, van Dam RM (2009) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32(6):1023–1025. doi:10.​2337/​dc09-0207 CrossRef
97.
Yoshinari O, Igarashi K (2010) Anti-diabetic effect of trigonelline and nicotinic acid, on KK-A(y) mice. Curr Med Chem 17(20):2196–2202CrossRef
98.
Mishkinsky J, Joseph B, Sulman FG (1967) Hypoglycaemic effect of trigonelline. Lancet 2(7529):1311–1312CrossRef
99.
100.
Yoshinari O, Sato H, Igarashi K (2009) Anti-diabetic effects of pumpkin and its components, trigonelline and nicotinic acid, on Goto-Kakizaki rats. Biosci Biotechnol Biochem 73(5):1033–1041. doi:10.​1271/​bbb.​80805 CrossRef
101.
de Valk HW (1999) Magnesium in diabetes mellitus. The Netherlands J Med 54(4):139–146CrossRef
102.
Belin RJ, He K (2007) Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome. Magnes Res 20(2):107–129
103.
Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardo A, Paolisso G (2003) Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Asp Med 24(1–3):39–52CrossRef
104.
Paolisso G, Scheen A, D’Onofrio F, Lefebvre P (1990) Magnesium and glucose homeostasis. Diabetologia 33(9):511–514CrossRef
105.
Clifford MN (1999) Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J Sci Food Agric 79:362–372CrossRef
106.
107.
108.
Robinson K, Prins J, Venkatesh B (2011) Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit Care 15(2):221. doi:10.​1186/​cc10021 CrossRef
109.
110.
111.
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Investig 116(7):1784–1792. doi:10.​1172/​JCI29126 CrossRef
112.
113.
van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294(1):97–104CrossRef
114.
115.
Paynter NP, Yeh HC, Voutilainen S, Schmidt MI, Heiss G, Folsom AR, Brancati FL, Kao WH (2006) Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Am J Epidemiol 164(11):1075–1084. doi:10.​1093/​aje/​kwj323 CrossRef
116.
van Dam RM (2006) Coffee consumption and the decreased risk of diabetes mellitus type 2. Ned Tijdschr Geneeskd 150(33):1821–1825
117.
van Dam RM (2006) Green tea, coffee, and diabetes. Ann Intern Med 145(8):634 (author reply 634–635)
118.
van Dam RM, Willett WC, Manson JE, Hu FB (2006) Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 29(2):398–403CrossRef
119.
Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 169(22):2053–2063. doi:10.​1001/​archinternmed.​2009.​439 CrossRef
120.
Hamer M, Witte DR, Mosdol A, Marmot MG, Brunner EJ (2008) Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: the Whitehall II study. Br J Nutr 100(5):1046–1053. doi:10.​1017/​S000711450894413​5 CrossRef
121.
Greenberg JA, Boozer CN, Geliebter A (2006) Coffee, diabetes, and weight control. Am J Clin Nutr 84(4):682–693
122.
Naismith DJ, Akinyanju PA, Szanto S, Yudkin J (1970) The effect, in volunteers, of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting. Nutr Metab 12(3):144–151CrossRef
123.
Crozier TW, Stalmach A, Lean ME, Crozier A (2012) Espresso coffees, caffeine and chlorogenic acid intake: potential health implications. Food Funct 3(1):30–33. doi:10.​1039/​c1fo10240k CrossRef
124.
Monteiro M, Farah A, Perrone D, Trugo LC, Donangelo C (2007) Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J Nutr 137(10):2196–2201
125.
Metadata
Title
Coffee consumption, obesity and type 2 diabetes: a mini-review
Authors
Roseane Maria Maia Santos
Darcy Roberto Andrade Lima
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 4/2016
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-016-1206-0

Other articles of this Issue 4/2016

European Journal of Nutrition 4/2016 Go to the issue

Original Contribution

Serum 25-hydroxyvitamin D is associated with reduced verbal episodic memory in healthy, middle-aged and older adults

Original Contribution

Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study

Original Contribution

Grape skin extract-derived polyphenols modify programming-induced renal endowment in prenatal protein-restricted male mouse offspring

Original Contribution

Energy and macronutrient intakes and adherence to dietary guidelines of infants and toddlers in Belgium

Original Contribution

Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett’s esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population

Original Contribution

Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits